Absci (ABSI) Margin of Safety % (DCF Dividends Based): N/A (As of Jul. 09, 2026)


ABSI Absci Corp ABSI
57 GF Score
Price $11.10
GF Value $1.83
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Absci Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

Absci's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.

ABSI vs ANAB, RXRX, TSHA: Margin of Safety % (DCF Dividends Based) Comparison

For the Biotechnology subindustry, Absci's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Absci Margin of Safety % (DCF Dividends Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Absci's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Absci's Margin of Safety % (DCF Dividends Based) falls into.


ABSI
57GF Score
Absci Corp ABSI
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Absci (ABSI) Overvalued in 2026?

Based on GuruFocus' analysis, Absci stock appears to be overvalued. The current stock price of $11.10 is trading 506.6% above its estimated GF Value™ of $1.83. GuruFocus considers Absci to be Significantly Overvalued.

Key valuation signals for ABSI:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: $1.83 vs. price of $11.10 (506.6% above fair value)
  • GF Score™: 57/100 with 6 warning signs

No single metric tells the full story. See the ABSI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Absci Business Description

Address 18105 SE Mill Plain Boulevard, Vancouver, WA, USA, 98683
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
57GF Score

Get the complete analysis for ABSI

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.10
Price
$1.83
GF Value